This gallery contains 1 photo.
ToxStrategies LLC is pleased to announce that Dr. Daniele Wikoff has been appointed as its new Chief Scientific Officer. Having had a key… read more
Author Archives: cmccormick
Case Study of In Silico Approach to Assessing Carcinogenicity
Two toxicologists from ToxStrategies’ Pharmaceuticals Practice are among the team with a new publication concerning the use of in silico (computer modeling) approaches… read more
Congressional Briefings on CBD Regulatory Status
New Publication Assessing Worker Exposure to 1,3-butadiene During Chemical Manufacturing
ToxStrategies’ Scientists Publish Acute/Short-term Inhalation Guideline for Manganese Supported by PBPK Modeling
ToxStrategies is Presenting at SETAC 2023
ToxStrategies’ scientists will be participating in The Society of Environmental Toxicology and Chemistry’s (SETAC) 44th Annual Meeting this year, November 12–16, in Louisville,… read more
Announcing HEORStrategies, the newest division of ToxStrategies LLC!
HEORStrategies provides robust, strategic health economics and outcomes research (HEOR) consulting services to pharma, biotech, and medical device clients!
EpidStrategies’ Scientists are Presenting on RSV at IDWeek 2023
EpidStrategies’ scientists are recognized experts in the field of respiratory syncytial virus (RSV). Our RSV research program supported the newly-approved monoclonal antibody with… read more